Physician profile
Cameron S Cunningham
NPI 1275943011
$7,923.08
in general payments reported to CMS, 2019-2025
19 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $641 · 2021: $1,635 · 2022: $1,585 · 2023: $935 · 2024: $1,254 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,232.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,850.13 | 2019-2025 | Eterna, Proclaim, Octrode |
| Boston Scientific Corporation | $2,185.18 | 2020-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Nevro Corp. | $902.71 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $852.19 | 2019-2025 | Sprint Pns System |
| Medtronic, INC. | $273.39 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Relievant Medsystems, INC. | $263.29 | 2021 | |
| Nalu Medical, INC. | $136.49 | 2021 | |
| Medtronic USA, INC. | $81.32 | 2019 | |
| Curonix LLC | $68.18 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Avanos Medical | $58.24 | 2019 | |
| Forte Bio-Pharma LLC | $53.32 | 2021-2023 | Prolate, Nalocet |
| Abbvie INC. | $39.96 | 2022 | |
| Globus Medical, INC. | $30.00 | 2025 | Senza |
| Painteq LLC | $29.52 | 2022-2023 | Painteq |
| Biotronik Nro, INC. | $29.28 | 2025 | Prospera |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $21.28 | 2024 | Mild Device Kit |
| Merck Sharp & Dohme LLC | $19.79 | 2021 | |
| Lilly USA, LLC | $16.73 | 2022 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.